Patents by Inventor Ulrike Kurtkaya

Ulrike Kurtkaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-COV-2 NUCLEOCAPSID ANTIBODIES
    Publication number: 20230406909
    Abstract: The present invention relates to monoclonal antibodies binding to the nucleocapsid protein of SARS-CoV-2 virus, nucleic acids encoding said antibody, host cells producing the same, compositions and kits comprising said antibodies, as well as methods of detecting SARS-CoV-2 virus in a sample comprising using said antibodies.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 21, 2023
    Inventors: Michael Gerg, Ute Jucknischke, Ulrike Kurtkaya, Thomas Mock, Michael Schraeml, Sandrine Carolina Stiegler
  • Antibodies recognizing genetic variants of NT-proBNP
    Patent number: 11372000
    Abstract: The present disclosure relates to an antibody that specifically binds a mutated NT-proBNP having i) a mutation substituting arginine at position 46 with histidine or ii) a mutation substituting glutamic acid at position 43 with aspartic acid. Moreover, the present disclosure relates to a mutated NT-proBNP or fragment thereof. Further, envisaged by the present disclosure are kits containing the antibody of the present disclosure, or the mutated NT-proBNP of the present disclosure. The present disclosure also concerns a method for diagnosing heart failure.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: June 28, 2022
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Klaus Hallermayer, Monika Soukupova, Christina Porzig, Ulrike Kurtkaya, Leopold Von Proff, Sonja Fiesel, Marion Herrmann, Stefanie Kern
  • NOVEL ANTI-THYMIDINE KINASE ANTIBODIES
    Publication number: 20210061924
    Abstract: The present invention relates to a novel monoclonal antibody that specifically binds to a conformation dependent epitope on human thymidine kinase 1 (hTK-1; SEQ ID NO:1), to methods for quantifying hTK-1 employing the antibody and to the use of the anti-hTK-1 antibody in quantifying hTK-1.
    Type: Application
    Filed: October 13, 2020
    Publication date: March 4, 2021
    Inventors: Hartmut Duefel, Alfred Engel, Frank Kroner, Thomas Meier, Sandra Rutz, Michael Schraeml, Gloria Tabares, Ulrike Kurtkaya, Boris Pinchuk, Christina Zimmermann
  • ANTIBODIES RECOGNIZING GENERIC VARIANTS
    Publication number: 20190369117
    Abstract: The present disclosure relates to an antibody that specifically binds a mutated NT-proBNP having i) a mutation substituting arginine at position 46 with histidine or ii) a mutation substituting glutamic acid at position 43 with aspartic acid. Moreover, the present disclosure relates to a mutated NT-proBNP or fragment thereof. Further, envisaged by the present disclosure are kits containing the antibody of the present disclosure, or the mutated NT-proBNP of the present disclosure. The present disclosure also concerns a method for diagnosing heart failure.
    Type: Application
    Filed: August 13, 2019
    Publication date: December 5, 2019
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Klaus Hallermayer, Monika Soukupova, Christina Porzig, Ulrike Kurtkaya, Leopold Von Proff, Sonja Fiesel, Marion Herrmann, Stefanie Kern